Dave Ricks

Dave Ricks

Up next

Raj Subramaniam

FedEx President and CEO Raj Subramaniam discusses how the company moves nearly $2 trillion worth of goods annually, its use of AI and data analytics, autonomous trucking, and the massive transformation underway inside FedEx. He also shares his personal journey from Kerala, India ...  Show more

Charlie Scharf

Wells Fargo Chairman and CEO Charlie Scharf says the independence of the Federal Reserve is "critically important" to the the US financial system, even as presidents weigh in on policy. In this wide-ranging interview, Scharf discusses the state of US economy amid tensions with Ir ...  Show more

Recommended Episodes

Benjamin Y. Fong, "Quick Fixes: Drugs in America from Prohibition to the 21st Century Binge" (Verso, 2023)
New Books in Public Policy

Benjamin Y. Fong is author of the new book Quick Fixes: Drugs in America from Prohibition to the 21st Century Binge, which was just released in July, 2023 by Verso Books. Ben is an honors faculty fellow and associate director of the Center for Work & Democracy at Arizona State Un ...  Show more

Market Rally Aims for “Cloud Nine,” Bronfman's Paramount Bid, Eli Lilly CEO on Weight-Loss Drug 8/20/24
Squawk on the Street

Carl Quintanilla and Jim Cramer led off the show by delving into the broadening market rally, as the S&P 500 and Nasdaq aim for a ninth consecutive day of gains. David Faber called into the show with reporting on Edgar Bronfman's bid to acquire Paramount Global. Eli Lilly CEO ...

  Show more

HIGHLIGHTS: David Ricks - CEO of Eli Lilly
In Good Company with Nicolai Tangen

We've curated a special 10-minute version of the podcast for those in a hurry.   Here you can listen to the full episode:  https://podcasts.apple.com/no/podcast/eli-lilly-ceo-the-weight-loss-drug-revolution-ai-in/id1614211565?i=1000693848152&l=nb Nicolai Tangen meets with David Ri ...  Show more

ICYMI: Eli Lilly's New Weight Loss Pill
Bloomberg Businessweek

Shares in Eli Lilly surged on Friday  after its experimental pill helped patients shed weight and control blood sugar about as well as Ozempic, an advance that could turbocharge what’s already one of the fastest growing markets in medicine. Shares of the drug’s originator Chugai ...  Show more